ISPC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.165

Open

0.160

VWAP

0.16

Vol

406.42K

Mkt Cap

1.53M

Low

0.159

Amount

65.71K

EV/EBITDA(TTM)

--

Total Shares

9.77M

EV

-1.25M

EV/OCF(TTM)

--

P/S(TTM)

0.14

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

Show More

Events Timeline

(ET)

2026-01-20

06:10:00

iSpecimen Files to Sell 101M Shares of Common Stock

2025-12-30 (ET)

2025-12-30

18:30:00

iSpecimen Shares Rise 36.9% After $5.5M Private Placement Announcement

2025-12-30

14:50:00

iSpecimen Enters $5.5M Securities Purchase Agreement with Investors

2025-07-24 (ET)

2025-07-24

08:41:24

iSpecimen prices 5.7M shares at 70c in underwritten public offering

2024-11-07 (ET)

2024-11-07

06:49:54

iSpecimen releases cancer biospecimen offering

2024-11-07

06:10:18

iSpecimen reports Q3 EPS ($2.10) vs ($4.66) last year

2024-10-18 (ET)

2024-10-18

17:27:44

iSpecimen files to sell 1.22M shares of common stock

2024-09-26 (ET)

2024-09-26

07:33:06

iSpecimen secures $1M loan, appoints three board members

2024-09-11 (ET)

2024-09-11

16:34:31

iSpecimen announces 1-for-20 reverse stock split

News

Benzinga

U.S. Stocks Rise in Morning Trade Amid Economic Slowdown

Benzinga

The Oncology Institute Reports Strong Q4 Results, Shares Surge

NASDAQ.COM

03-13NASDAQ.COM

iSpecimen Shares Surge 62% Following AI Inventory Agent Launch

Benzinga

iSpecimen Shares Surge 42.99% After AI Tool Launch

Benzinga

Roblox Reports Quarterly Earnings Exceeding Expectations

NASDAQ.COM

01-05NASDAQ.COM

Insilico Medicine Partners with Servier for $888 Million Oncology R&D Collaboration

Valuation Metrics

The current forward P/E ratio for iSpecimen Inc (ISPC.O) is 0.00, compared to its 5-year average forward P/E of -13.49. For a more detailed relative valuation and DCF analysis to assess iSpecimen Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-13.49

Current PE

0.00

Overvalued PE

41.36

Undervalued PE

-68.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-1.48

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

2.24

Undervalued EV/EBITDA

-5.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

1.44

Current PS

0.00

Overvalued PS

3.24

Undervalued PS

-0.37

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

high volume low float stocks

Intellectia · 69 candidates

Region: USVolume: >= 1,000,000Floating Shares: <= 30,000,000

Ticker

Name

Market Cap$

Paranovus Entertainment Technology Ltd

1.28M

Hitek Global Inc

2.10M

Meiwu Technology Co Ltd

2.04M

Actelis Networks Inc

10.05M

urban-gro Inc

5.28M

Erayak Power Solution Group Inc

370.63K

Daily momentum stocks

Intellectia · 81 candidates

Price Change Pct: >= $3.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20

Ticker

Name

Market Cap$

bioAffinity Technologies Inc

9.54M

Firefly Neuroscience Inc

39.09M

Silvaco Group Inc

154.11M

iSpecimen Inc

2.78M

Oruka Therapeutics Inc

1.94B

Sow Good Inc

6.16M

big gainers today

Intellectia · 137 candidates

Price Change Pct: >= $5.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

PEDEVCO Corp

206.16M

bioAffinity Technologies Inc

4.81M

iSpecimen Inc

2.19M

Firefly Neuroscience Inc

24.73M

eLong Power Holding Ltd

407.04M

Silvaco Group Inc

101.11M

tech stocks under 200 ma

Intellectia · 256 candidates

Market Cap: <= 200.00MSector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology EquipmentList Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

Boxlight Corp

1.27M

Sobr Safe Inc

1.38M

SmartKem Inc

1.93M

My Size Inc

2.08M

CCSC Technology International Holdings Ltd

2.17M

Webuy Global Ltd

2.22M

Whales Holding ISPC

Trading Trends

People Also Watch

Frequently Asked Questions

What is iSpecimen Inc (ISPC) stock price today?

The current price of ISPC is 0.16 USD — it has increased 1.91

What is iSpecimen Inc (ISPC)'s business?

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

What is the price predicton of ISPC Stock?

Wall Street analysts forecast ISPC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is iSpecimen Inc (ISPC)'s revenue for the last quarter?

iSpecimen Inc revenue for the last quarter amounts to 106.59K USD, decreased -96.00

What is iSpecimen Inc (ISPC)'s earnings per share (EPS) for the last quarter?

iSpecimen Inc. EPS for the last quarter amounts to -0.48 USD, decreased -77.14

How many employees does iSpecimen Inc (ISPC). have?

iSpecimen Inc (ISPC) has 24 emplpoyees as of April 01 2026.

What is iSpecimen Inc (ISPC) market cap?

Today ISPC has the market capitalization of 1.53M USD.